Factors Associated With Willingness to Receive a COVID-19 Vaccine Among 23,819 Adults Aged 50 Years or Older : An Analysis of the Canadian Longitudinal Study on Aging

© The Author(s) 2022. Published by Oxford University Press on behalf of the Johns Hopkins Bloomberg School of Public Health..

Identifying persons who are least willing to receive a coronavirus disease 2019 (COVID-19) vaccine is critical for increasing uptake via targeted outreach. We conducted a survey of 23,819 Canadian Longitudinal Study on Aging participants from September 29 to December 29, 2020, to assess factors associated with COVID-19 vaccination willingness and reasons for willingness or lack thereof. Among adults aged 50-96 years, 84.1% (95% confidence interval (CI): 83.7, 84.6) were very or somewhat willing to receive a COVID-19 vaccine; 15.9% (95% CI: 15.4, 16.3) were uncertain or very or somewhat unwilling. Based on logistic regression, those who were younger, female, had lower education and income, were non-White, and lived in a rural area were less willing to receive a COVID-19 vaccine. After controlling for these factors, recent receipt of influenza vaccine (adjusted odds ratio = 14.3, 95% CI: 12.5, 16.2) or planning to receive influenza vaccine (adjusted odds ratio = 10.5, 95% CI: 9.5, 11.6), as compared with no receipt or planning, was most strongly associated with COVID-19 vaccination willingness. Willingness was also associated with believing one had never been infected with severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) and experiencing negative pandemic consequences. Safety concerns were most common among those unwilling. Our comprehensive assessment of COVID-19 vaccination willingness among older adults in Canada, a prioritized group for vaccination due to their risk of severe COVID-19 outcomes, provides a road map for conducting outreach to increase uptake, which is urgently needed.

Medienart:

E-Artikel

Erscheinungsjahr:

2022

Erschienen:

2022

Enthalten in:

Zur Gesamtaufnahme - volume:191

Enthalten in:

American journal of epidemiology - 191(2022), 6 vom: 20. Mai, Seite 987-998

Sprache:

Englisch

Beteiligte Personen:

Basta, Nicole E [VerfasserIn]
Sohel, Nazmul [VerfasserIn]
Sulis, Giorgia [VerfasserIn]
Wolfson, Christina [VerfasserIn]
Maimon, Geva [VerfasserIn]
Griffith, Lauren E [VerfasserIn]
Kirkland, Susan [VerfasserIn]
McMillan, Jacqueline M [VerfasserIn]
Thompson, Mary [VerfasserIn]
Raina, Parminder [VerfasserIn]
for the Canadian Longitudinal Study on Aging (CLSA) Research Team [VerfasserIn]

Links:

Volltext

Themen:

Adults
COVID-19
COVID-19 Vaccines
Canada
Canadian Longitudinal Study on Aging
Coronavirus disease 2019
Influenza Vaccines
Journal Article
Research Support, Non-U.S. Gov't
SARS-CoV-2
Vaccination
Vaccines

Anmerkungen:

Date Completed 08.06.2022

Date Revised 16.07.2022

published: Print

Citation Status MEDLINE

doi:

10.1093/aje/kwac029

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM336984049